APA (7th ed.) Citation

Jiang, H., Liu, X., Kong, J., Wang, J., Jia, J., Lu, S., . . . Huang, X. (2021). Interferon-α as maintenance therapy can significantly reduce relapse in patients with favorable-risk acute myeloid leukemia. Leukemia & Lymphoma, 62(12), 2949. https://doi.org/10.1080/10428194.2021.1948027

Chicago Style (17th ed.) Citation

Jiang, Hao, et al. "Interferon-α as Maintenance Therapy Can Significantly Reduce Relapse in Patients with Favorable-risk Acute Myeloid Leukemia." Leukemia & Lymphoma 62, no. 12 (2021): 2949. https://doi.org/10.1080/10428194.2021.1948027.

MLA (9th ed.) Citation

Jiang, Hao, et al. "Interferon-α as Maintenance Therapy Can Significantly Reduce Relapse in Patients with Favorable-risk Acute Myeloid Leukemia." Leukemia & Lymphoma, vol. 62, no. 12, 2021, p. 2949, https://doi.org/10.1080/10428194.2021.1948027.